Abbott India Ltd. Stock Falls to 52-Week Low of Rs.26000

Stock Price Movement and Market Context

The stock of Abbott India Ltd. (Stock ID: 919728) recorded a fresh 52-week low at Rs.26000 on 2 Mar 2026. Despite this low, the stock outperformed its sector by 1.14% today and has gained 0.88% over the last two consecutive trading days. The price currently trades above its 5-day moving average but remains below its 20-day, 50-day, 100-day, and 200-day moving averages, indicating a mixed short-term technical picture amid longer-term weakness.

In comparison, the Sensex opened sharply lower by 2,743.46 points but recovered 1,278.04 points to trade at 79,821.77, still down 1.8% on the day. The Sensex itself is trading below its 50-day moving average, though the 50DMA remains above the 200DMA, suggesting some underlying market resilience despite recent volatility.

Performance Over the Past Year

Abbott India Ltd. has underperformed the broader market significantly over the last 12 months. The stock has delivered a negative return of -12.83%, contrasting with the Sensex’s positive 9.03% gain over the same period. The 52-week high for the stock was Rs.35921.55, highlighting the extent of the decline from its peak.

Over the longer term, the stock has also lagged behind the BSE500 index across one year, three years, and the last three months, reflecting persistent challenges in regaining investor confidence and market share.

Financial Metrics and Valuation Concerns

Abbott India Ltd.’s recent financial results have been largely flat, with the December 2025 quarter showing no significant growth. Key efficiency ratios such as the inventory turnover ratio and debtors turnover ratio for the half-year period stand at 7.16 times and 13.24 times respectively, both among the lowest in recent years. These ratios suggest slower movement of inventory and receivables, which may be impacting cash flow dynamics.

The company’s return on equity (ROE) remains robust at 38%, indicating strong profitability relative to shareholder equity. However, this is accompanied by a high price-to-book value ratio of 14, signalling a very expensive valuation relative to its book value. Despite this, the stock is trading at a discount compared to its peers’ average historical valuations, reflecting market caution.

Profit growth over the past year has been positive at 14.2%, yet the price/earnings to growth (PEG) ratio stands at 2.6, which is on the higher side, suggesting that earnings growth may not be fully reflected in the current stock price.

Long-Term Performance and Industry Position

While Abbott India Ltd. has demonstrated strong long-term fundamentals, including an average ROE of 34.23% and an annual operating profit growth rate of 17.25%, these strengths have not translated into sustained stock price appreciation. The company maintains a low average debt-to-equity ratio of zero, underscoring a conservative capital structure with minimal leverage.

Promoters remain the majority shareholders, maintaining significant control over the company’s strategic direction.

Mojo Score and Analyst Ratings

Abbott India Ltd. currently holds a Mojo Score of 44.0, which places it in the ‘Sell’ category. This represents a downgrade from its previous ‘Hold’ rating as of 12 Jan 2026. The company’s market cap grade is 2, reflecting its mid-cap status within the Pharmaceuticals & Biotechnology sector.

The downgrade reflects concerns over the company’s recent performance metrics and valuation, despite its strong fundamentals and sector positioning.

Summary of Key Data Points

• New 52-week low price: Rs.26000 (2 Mar 2026)
• 52-week high price: Rs.35921.55
• 1-year stock return: -12.83%
• Sensex 1-year return: +9.03%
• Inventory turnover ratio (HY): 7.16 times
• Debtors turnover ratio (HY): 13.24 times
• Return on equity (ROE): 38%
• Price to book value: 14
• PEG ratio: 2.6
• Operating profit growth (annual): 17.25%
• Debt to equity ratio (average): 0
• Mojo Score: 44.0 (Sell, downgraded from Hold on 12 Jan 2026)

Conclusion

Abbott India Ltd.’s stock reaching a 52-week low of Rs.26000 highlights the pressures faced by the company in the current market environment. Despite solid profitability and growth in operating profit, valuation concerns and below-par stock performance relative to benchmarks have weighed on investor sentiment. The company’s conservative capital structure and promoter backing remain notable features amid this challenging phase.

Limited Period Only. Start at Rs. 9,999 - Get MojoOne for 1 Year + 3 Months FREE (60% Off) Get 71% Off →